Lonny Elson, NP
Primary Care · Flagstaff, AZNPI 1912192048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 78 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$340
- AbbVie$322
- Novartis$245
- EMD Serono, Inc.$163
- Eisai Inc.$125
- Novo Nordisk$113
- plus $476 from 12 others
What the payments were for
- Food & beverage$1,75899%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $340 |
| AbbVie | 11 | $322 |
| Novartis | 11 | $245 |
| EMD Serono, Inc. | 7 | $163 |
| Eisai Inc. | 5 | $125 |
| Novo Nordisk | 6 | $113 |
| Lilly USA, LLC | 6 | $109 |
| UCB, Inc. | 2 | $59 |
| Sanofi | 2 | $57 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Currax Pharmaceuticals LLC | 2 | $41 |
| Viatris Specialty LLC | 1 | $31 |
| Vivus LLC | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$125
How this compares
$1,783 in reported general payments places this provider in the 80th percentile of 151 primary care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $284 |
| Pantoprazole Sodium | 15 | $279 |
| Duloxetine Hcl | 14 | $261 |
| Memantine Hcl | 11 | $209 |
| Levothyroxine Sodium | 21 | $201 |
| Tamsulosin Hcl | 13 | $185 |
| Trazodone Hcl | 15 | $176 |
| Donepezil Hcl | 12 | $79 |
| Lisinopril | 11 | $56 |
| Amlodipine Besylate | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Other primary care in Flagstaff
- Trey PowrzanasPhoenix$16K
- Christine Rocks-LopezPhoenix$14K
- Elena KlimovaPhoenix$8K
- Albert VillafaniaPhoenix$8K
- Daniela HaimovPhoenix$8K
- Lea NickolasAvondale$7K
- Neena VargheseSacaton$6K
- Katy DodtQueen Creek$5K
- Mercy GeorgeQueen Creek$5K
- Charity CorreaPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.